Saugeen Ojibway Nation Territory

Made-in-Ontario Pumped Storage will enhance province’s energy supply mix

Retrieved on: 
Thursday, January 11, 2024

Further, TC Energy and Saugeen Ojibway Nation will assist with the Ministry’s evaluation of the Project’s broader societal and economic benefits.

Key Points: 
  • Further, TC Energy and Saugeen Ojibway Nation will assist with the Ministry’s evaluation of the Project’s broader societal and economic benefits.
  • The Ontario Pumped Storage Project represents a made-in-Ontario solution – it will be designed, engineered, and built by a domestic supply chain.
  • Further, TC Energy will provide a report to the Ministry with a breakdown of estimated development costs and schedule.
  • TC Energy will also provide further information to assist with the Government’s assessment of the Project’s societal and economic benefits.

TC Energy reports solid second quarter 2023 results, while significantly advancing Coastal GasLink and Southeast Gateway projects to planned cost and schedule

Retrieved on: 
Thursday, July 27, 2023

CALGARY, Alberta, July 27, 2023 (GLOBE NEWSWIRE) -- TC Energy Corporation (TSX, NYSE: TRP) (TC Energy or the Company) released its second quarter results today. François Poirier, TC Energy’s President and Chief Executive Officer commented, “Today’s announcement to separate our Natural Gas Pipelines and Power and Energy Solutions businesses from our Liquids Pipelines business will maximize the value of our assets. The separated industry-leading companies will have greater strategic focus to execute major projects, drive efficiencies and operational excellence, and enhanced flexibility to pursue disciplined growth." Poirier continued, “In addition, we have made significant progress on our 2023 strategic priorities. First, we continue to safely execute our secured capital program, including Coastal GasLink and Southeast Gateway which remain on planned cost and schedule. Second, we have significantly accelerated our deleveraging goal ahead of our year-end target with the sale of a 40 per cent equity interest in the Columbia Gulf and Columbia Gas systems for total cash proceeds of $5.2 billion. And third, we are safely and reliably operating our assets that provide essential services across North America, which is a testament to the dedication and hard work of our people.”

Key Points: 
  • We remain laser focused on our 2023 priorities and have achieved significant milestones during the first half of the year.
  • We continue to safely execute major projects like Coastal GasLink and Southeast Gateway that continue to track cost and schedule.
  • TC Energy will focus on natural gas, driven by strong long-term fundamentals and power and energy solutions, driven by nuclear, pumped hydro energy storage and new energy opportunities.
  • During the second quarter of 2023, we saw continued strong demand for our critical energy assets.

TC Energy’s Pumped Storage Project moving to final evaluation

Retrieved on: 
Monday, July 10, 2023

As part of the announcement, the Ministry of Energy will now commence a final evaluation on the proposed Ontario Pumped Storage Project (the Project) and render a decision by the end of the year.

Key Points: 
  • As part of the announcement, the Ministry of Energy will now commence a final evaluation on the proposed Ontario Pumped Storage Project (the Project) and render a decision by the end of the year.
  • Ontario Pumped Storage is a made-in-Ontario solution that would keep jobs at home and rely on safe domestic supply chains.
  • Proposed for development by TC Energy and its prospective partner Saugeen Ojibway Nation, Ontario Pumped Storage would be Ontario’s largest energy storage project, storing enough clean electricity to power one million homes for 11 hours.
  • By Nov. 30, 2023, the Minister of Energy will make a final determination on Ontario Pumped Storage.

Ontario government supports long-term planning and consultation work to explore the expansion of clean nuclear at Bruce Power

Retrieved on: 
Wednesday, July 5, 2023

Todd Smith, announced support to advance the long-term planning and consultation work required to explore nuclear expansion options on the Bruce Power site.

Key Points: 
  • Todd Smith, announced support to advance the long-term planning and consultation work required to explore nuclear expansion options on the Bruce Power site.
  • “Bruce Power is a leader in producing clean, reliable energy for people in Huron-Bruce County and across the province,” said Hon.
  • Bruce Power is committed to meaningful engagement, and consultation with local Indigenous communities, including opportunities for participation.
  • The long-term planning and consultation activities will not impact the company’s Life-Extension Program that will secure the site’s operation through 2064.

Government of Canada teams up with Indigenous partners, Bruce Power and the medical isotope community to fight cancer

Retrieved on: 
Tuesday, June 27, 2023

The partnership includes Indigenous communities, Ontario’s nuclear industry, and leading research facilities, academics, and firms working to commercialize novel therapies.

Key Points: 
  • The partnership includes Indigenous communities, Ontario’s nuclear industry, and leading research facilities, academics, and firms working to commercialize novel therapies.
  • This funding will ultimately enable a pan-Canadian consortium – the Canadian Medical Isotope Ecosystem (CMIE) – to advance and accelerate the development of the next generation of novel medical isotopes and technologies.
  • “Canada is a world leader in medical isotope research and production, and Bruce Power is proud to be among the innovative companies that places Canada at the forefront of nuclear medicine,” said Mike Rencheck, Bruce Power’s President and CEO.
  • “Our government is proud to partner in the creation of the Canadian Medical Isotope Ecosystem, which includes support for the SON First Nations communities’ partnership with Bruce Power to innovate in the fight against cancer,” said Minister Champagne.

Government strengthens Canada's leadership role in medical isotope production

Retrieved on: 
Tuesday, June 27, 2023

Canada has played a key leadership role in the development and use of medical isotopes for over 70 years, positioning the country as a global leader in the production and supply of medical isotopes.

Key Points: 
  • Canada has played a key leadership role in the development and use of medical isotopes for over 70 years, positioning the country as a global leader in the production and supply of medical isotopes.
  • This funding responds to the Canadian Nuclear Isotope Council's report, Isotopes for Hope: Canadian Leadership Needed Now More Than Ever, calling on the federal government to invest in the growth of Canada's medical isotope ecosystem.
  • The Canadian Medical Isotope Ecosystem will play a crucial role in the development and distribution of medical isotopes and radiopharmaceuticals across the country.
  • The new Canadian Medical Isotope Ecosystem brings together government, industry and academia to work collaboratively to build Canadian medical isotope capabilities and ensure Canada remains a leader in this high-growth sector."

Isotope Production System begins commercial production of cancer-fighting lutetium-177

Retrieved on: 
Monday, October 24, 2022

The IPS will provide reliable, industrial-scale production of lutetium-177, a medical isotope used for targeted cancer therapeutics.

Key Points: 
  • The IPS will provide reliable, industrial-scale production of lutetium-177, a medical isotope used for targeted cancer therapeutics.
  • Todays announcement is a huge step forward in advancing Ontario as a world leader of isotope production in the fight against cancer.
  • It is with great pride that we at Bruce Power, along with our partners at Isogen, ITM and Saugeen Ojibway Nation, celebrate the successful commencement of commercial operation of the worlds first large-scale Isotope Production System for the production of lutetium-177, said Mike Rencheck, Bruce Powers President and CEO.
  • lutetium-177 to health care facilities around the world, and the isotope has been successfully used in various clinical and commercial radiopharmaceutical cancer treatments.

ITM: Isotope Production System Begins Commercial Production of Cancer-Fighting Lutetium-177

Retrieved on: 
Monday, October 24, 2022

It marks the first-of-its-kind achievement of a commercial power reactor with additional capability to commercially produce short-lived medical isotopes.

Key Points: 
  • It marks the first-of-its-kind achievement of a commercial power reactor with additional capability to commercially produce short-lived medical isotopes.
  • The IPS will provide reliable, industrial-scale production of lutetium-177, a medical isotope used for targeted cancer therapeutics.
  • Todays announcement is a huge step forward in advancing Ontario as a world leader of isotope production in the fight against cancer.
  • lutetium-177 to health care facilities around the world, and the isotope has been successfully used in various clinical and commercial radiopharmaceutical cancer treatments.

Bruce Power to explore production of cancer-fighting medical isotope yttrium-90 for global distribution

Retrieved on: 
Monday, October 3, 2022

Medical isotopes save lives and Ontario is primed to become an isotope superpower, said Ontarios Energy Minister Todd Smith.

Key Points: 
  • Medical isotopes save lives and Ontario is primed to become an isotope superpower, said Ontarios Energy Minister Todd Smith.
  • Additionally, Bruce Power will soon become the first nuclear power reactor operator to commercially produce lutetium-177 through an innovative Isotope Production System (IPS).
  • The IPS is a first-of-its-kind solution to produce short-lived medical isotopes in a commercial reactor and will provide unprecedented capacity, redundancy and scale for medical isotope production.
  • Isogen will also work with Bruce Power and Boston Scientific on the feasibility of yttrium-90 production using the IPS.

New Isotope Production System at Bruce Power successfully produces first medical isotope

Retrieved on: 
Tuesday, June 21, 2022

This milestone was achieved using a new Isotope Production System (IPS) that was installed in Bruce Powers Unit 7 during a recent planned maintenance outage.

Key Points: 
  • This milestone was achieved using a new Isotope Production System (IPS) that was installed in Bruce Powers Unit 7 during a recent planned maintenance outage.
  • The IPS successfully irradiated targets to produce lutetium-177, a medical isotope used in precision oncology for targeted therapy of a growing number of cancers.
  • As part of commissioning activities, ytterbium-176 was successfully irradiated using the IPS, designed and installed by Isogen, to produce lutetium-177.
  • The exclusive access to the new Isotope Production System will allow ITM to further scale our global pharmaceutical n.c.a.